Skip to main content

Table 4 Health-Related Quality of Life by Time since Diagnosis and Cardiac Involvement

From: The burden of amyloid light chain amyloidosis on health-related quality of life

 

Time since diagnosis

 

Cardiac involvement

 
 

<12 months n = 52

≥12 months n = 289

 

No n = 163

Yes n = 178

 
 

Mean (SD)

Mean (SD)

P value

Mean (SD)

Mean (SD)

P value

SF-36v2 norm-based scalesa

 Physical functioning (PF)

38.7 (12.4)

43.2 (10.2)

0.015

44.5 (10.9)

40.7 (10.0)

<0.001

 Role physical (RP)

35.6 (12.7)

41.4 (10.9)

0.001

41.8 (11.7)

39.3 (10.9)

0.043

 Bodily pain (BP)

44.0 (11.6)

47.0 (10.4)

0.099

47.2 (10.8)

46.1 (10.4)

0.257

 General health (GH)

38.8 (11.7)

39.4 (10.3)

0.827

40.9 (10.5)

37.7 (10.4)

0.005

 Vitality (VT)

40.9 (12.1)

45.1 (10.8)

0.027

44.9 (11.5)

44.1 (10.7)

0.530

 Social functioning (SF)

38.7 (13.3)

44.5 (10.9)

0.003

43.8 (11.7)

43.5 (11.3)

0.786

 Role emotional (RE)

41.0 (15.1)

46.1 (11.5)

0.038

45.3 (12.0)

45.3 (12.5)

0.900

 Mental health (MH)

44.8 (13.0)

49.8 (10.0)

0.012

48.9 (10.8)

49.2 (10.5)

0.803

SF-36v2 Summary Scores

 P Physical Component Summary (PCS)

38.2 (11.9)

41.2 (9.9)

0.064

42.7 (10.6)

38.9 (9.6)

<0.001

 Mental Component Summary (MCS)

43.5 (13.5)

48.7 (11.1)

0.012

47.2 (11.9)

48.5 (11.4)

0.348

Global assessment of functioning

59.1 (31.2)

72.2 (21.6)

0.015

73.1 (23.5)

67.5 (23.7)

0.013

Patient Global Impression–Severity Scale (PGI-S)

n

%

n

%

 

n

%

n

%

 
    

<0.001

    

<0.001

 Not severe at all

11

21.2

122

42.2

 

84

51.5

49

27.5

 

 Mild

12

23.1

80

27.7

 

40

24.5

52

29.2

 

 Moderate

15

28.8

66

22.8

 

26

16.0

55

30.9

 

 Severe

9

17.3

14

4.8

 

8

4.9

15

8.4

 

 Very severe

5

9.6

7

2.4

 

5

3.1

7

3.9

 
  1. aSF-36v2, SF-36v2 Health Survey